Lv4
580 积分 2023-02-18 加入
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial
17天前
已完结
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention
19天前
已完结
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management
1个月前
已完结
Complete versus incomplete coronary revascularization: definitions, assessment and outcomes
1个月前
已完结
Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging
1个月前
已完结
DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIODAPTOR-RCT
2个月前
已完结
Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
3个月前
已完结
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
3个月前
已完结
Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
3个月前
已完结
Bleeding avoidance strategies in percutaneous coronary intervention
3个月前
已完结
皖公网安备34019202002308
